Clinical Trial Update: Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo) [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating lurbinectedin plus doxorubicin versus doxorubicin alone as first-line treatment for metastatic leiomyosarcoma; recruitment is ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Lurbinectedin (lurbinectedin)

Snippet

Sponsor: PharmaMar | Conditions: Leiomyosarcoma | Phase 3 | Status: RECRUITING